awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q34734676-C626E41F-04BE-46D2-9A97-4E950FEEE25B
Q34734676-C626E41F-04BE-46D2-9A97-4E950FEEE25B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34734676-C626E41F-04BE-46D2-9A97-4E950FEEE25B
Successful management of enzyme replacement therapy in related fabry disease patients with severe adverse events by switching from agalsidase Beta (fabrazyme(®)) to agalsidase alfa (replagal (®)).
P2860
Q34734676-C626E41F-04BE-46D2-9A97-4E950FEEE25B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34734676-C626E41F-04BE-46D2-9A97-4E950FEEE25B
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
fca68d5b9761e1ca76a643fb3206e38e461a5bf1
P2860
Angiokeratoma corporis diffusum--Fabry disease: historical review from the original description to the introduction of enzyme replacement therapy.